
Beta Bionics, Inc. (BBNX) Stock Price & Analysis
BBNXNASDAQHealthcareMedical Devices
As of Nov 20, 2026 close
- Market cap
- $619.94M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $8.80$32.71
- Volume (live)
- -
- Avg. volume (3M)
- 1.15M
Beta Bionics (BBNX) Stock Price Chart
Loading chart...
BBNX Key Statistics & Financial Metrics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $12.92 - $13.85 |
|---|---|
| 52-Week High | $32.71 |
| 52-Week Low | $8.80 |
| Open | $13.05 |
| Volume (last close) | 960.31K |
| Average Volume (3M) | 1.15M |
| Revenue (TTM) | 127.27M |
|---|---|
| Net Income (TTM) | −83.12M |
| Free Cash Flow (TTM) | −65.96M |
| EPS (TTM) | −$1.89 |
| Profit Margin | −65.31% |
| Operating Margin | −72.75% |
| Return on Equity (ROE) | −20.71% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 619.94M |
|---|---|
| Shares Outstanding | 46.54M |
| Price to Sales (P/S) | 4.87 |
| Price to Book (P/B) | 1.54 |
| EV/EBITDA | -6.32 |
| 50-Day MA | $18.10 |
|---|---|
| 200-Day MA | $14.82 |
| 1-Year Change | −57.61% |
Source: Market prices and company fundamentals. Data as of Nov 20, 2026. Data sources and methodology
Beta Bionics at a Glance
As of the Nov 20, 2026 close, Beta Bionics (BBNX) has a market capitalization of $619.94M. The stock trades at 4.9× sales. Over the trailing twelve months it lost $83.12M on revenue of $127.27M and burned $65.96M of free cash flow. Revenue grew 43.7% year over year.
As of its latest reported balance sheet, it holds $81.55M in cash and securities against $4.65M of debt, a net cash position of $76.90M.
Beta Bionics does not currently pay a dividend.
The share price is down 57.6% over the past year. At $13.36 (the Nov 20, 2026 close) it sits within its 52-week range of $8.80 to $32.71, below its 200-day moving average of $14.82.
Based on 15 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $25.23, 88.8% above the Nov 20, 2026 close.
ETFs Holding BBNX
Largest funds holding BBNX, by assets
As of Oct 4, 2026, Beta Bionics (BBNX) is among the top 50 holdings of 1 US ETF.
| ETF | Name | Weight | AUM | Expense Ratio |
|---|---|---|---|---|
| IHI | iShares U.S. Medical Devices ETF | 0.14% | $3.53B | 0.37% |
Source: ETF top holdings as reported by fund issuers (largest ~50 positions per fund). Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Beta Bionics
What is the current stock price for BBNX?
As of the Nov 20, 2026 close, BBNX stock trades at $13.36. The 52-week range is $8.80–$32.71, with a day range of $12.92–$13.85.
What is the P/E ratio for BBNX?
Beta Bionics has no trailing P/E ratio because it reported a net loss over the last twelve months.
Does BBNX pay dividends?
Beta Bionics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BBNX?
Based on ratings from 15 professional analysts over the last 90 days, the consensus for BBNX is Buy. The average 12-month price target is $25.23, a 88.8% upside from the Nov 20, 2026 close of $13.36.
What is the market cap of BBNX?
As of the Nov 20, 2026 close, Beta Bionics' market capitalization is $621.8M, classifying it as a small-cap company. Beta Bionics operates in the Healthcare sector within the Medical Devices industry.